Howard C. Margolese, MSc, MD, CM, FRCPC

Department of Psychiatry, McGill University, Montreal, Quebec, Canada

  • 5Articles
  • 9.1KReads
  • 2002–2025Active
  • 40Collaborators
  • 14Citations

About

Howard C. Margolese, MSc, MD, CM, FRCPC, is affiliated with the Department of Psychiatry at McGill University in Montreal, Quebec, Canada. Between 2002 and 2025, Margolese has published extensively on topics including major depressive disorder, bipolar disorder, neurology, and schizophrenia/schizoaffective disorders. His work covers clinical areas such as personalized depression treatment using artificial intelligence, pharmacotherapy for trichotillomania, metabolic effects of antipsychotic medications, and neuropsychiatric complications in bipolar disorder. Margolese frequently collaborates with co-authors such as Soham Rej, Alexandra Anacleto, and Boadie W. Dunlop.

Publications

JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
Original Research

Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management

August 27, 2025

This study provides preliminary evidence that longitudinal use of an AI-enabled clinical decision support system can improve outcomes in MDD.
, , , et al
PCC
Letter to the Editor

Diabetes Insipidus Secondary to Combination Atypical Antipsychotic and Lithium Use in a Bipolar Disorder Patient: A Case Report

July 21, 2011

, ,
JCP
Letter to the Editor

Alternative Pharmacotherapy for Trichotillomania: A Report of Successful Bupropion Use

September 1, 2004

,
JCP
Original Research

Depression and Dysphoria in Adult and Adolescent Patients With Tourette's Disorder Treated With Risperidone

November 1, 2002

, ,
JCP
Letter to the Editor

Topiramate Produced Weight Loss Following Olanzapine-Induced Weight Gain in Schizophrenia

November 1, 2002

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe